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Literature: HPV is the most prevalent STI in the United States. Although a vaccine to 
prevent HPV infection exists, only 49.5% of females were up-to-date on the recommended 
vaccination HPV vaccination series in 2016. Though recommended for younger individuals, 
there is a catch-up period for females ages 18-26, which shows consistent under-participation. 
One potential risk factor for non-vaccination may be relationship status. Unlike other sexual 
health issues where monogamous, long-term relationships serve as a protective factor, such 
relationships may negatively impact HPV infection risk perception. Building from previous 
qualitative research, this study examined the quantitative association between relationship status 
and HPV vaccination behavior. 
Methodology: This exploratory cross-sectional study included an electronic survey 
among females 18-26 years old (N=629) who attend a large public university in the mid-Atlantic 
region. Bivariate and descriptive statistics were estimated using SPSS 24 to explore likelihood of 
vaccination during the catch-up age-range by relationship status. 
Results: Of participants, most were Caucasian (82.5%), undergraduate students (92.8%), 
who had received the HPV vaccine (79.0%), of which 7.9% received the vaccine during the 
catch-up period. Being Single and Dating was associated with vaccination during the catch-up 
period compared to all other relationship groups (X2 (1) = 4.87, p < 0.05; OR = 0.49, 95% CI 
0.25 – 0.93). 
Discussion: Single and Dating status was found to be a protective factor for participating 
in catch-up vaccination, potentially due to increased risk perception. Limitations include unique 
characteristics of the student population which limited variability in married/monogamous 
relationship status. Future research should continue to examine relationship status as a barrier to 
participation in catch-up vaccination. 
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Human Papillomavirus (HPV) is the most prevalent sexually transmitted infection in the 
United States and nearly all sexually active individuals will contract it at some point in their lives 
(Centers for Disease Control and Prevention [CDC], 2017). This has serious implications, as 
HPV is associated with several types of cancer, including: cervical, anal, vaginal, vulvar, penile, 
and oropharyngeal cancer (CDC, 2017). Although there is an effective vaccine to prevent HPV 
infection, only 49.5% of U.S. females were up-to-date on the recommended HPV vaccination 
series in 2016 (Walker et al., 2017). This is of particular importance because young adult females 
have the highest prevalence of contracting HPV, as over half of college-aged females will 
contract HPV within four years after her first sexual intercourse (Saslow et al., 2007). The 
vaccine is targeted toward individuals who are 11-12 years old, though the recommended catch-
up vaccination period for females is ages 18-26 (Markowitz et al., 2014). The catch-up period of 
HPV vaccination refers to the opportunity for previously unvaccinated young females to receive 
the vaccine before the age of 26 and still receive its benefits. It is important for young women to 
engage in this behavior if they have not previously been vaccinated. 
Despite an increasing trend in HPV vaccination in adolescents in recent years, there 
remains a consistent lack of participation among this catch-up age group (Schmidt & Parsons, 
2014). There are several important barriers to receiving vaccination among this group, including: 
cost-considerations, feeling the vaccine is unnecessary, safety concerns, healthcare provider 
recommendation, and social norms (Rambout, Tashkandi, Hopkins, & Tricco, 2014). A 
systematic review found that among twenty two studies conducted on barriers to vaccination for 
females in Canada and the United States, cost of the vaccine was the most common self-reported 
barrier (Rambout et al., 2014). Second to this factor was women feeling that the vaccine was not 






needed, as many women viewed their risk for contracting HPV as low (Rambout et al., 2014). 
This review also frequently identified that concerns about the safety and potential side effects of 
the vaccine are a significant barrier to uptake, as well as a low level of knowledge and awareness 
about HPV (Rambout et al., 2014). Insufficient provider communication and current sexual 
inactivity were also associated with non-vaccination (Rambout et al., 2014). 
The risk factor for non-vaccination behavior that this study was focused on was 
relationship status. Long-Term, Monogamous relationships are a barrier to females ages 18-26 
receiving the vaccine (Thompson, Vamos, Straub, Sappenfield, & Daley, 2017). This type of 
relationship status is typically perceived as a protective factor against sexually transmitted 
infections, however with HPV this is not the case (Burchell, Winer, de Sanjose, & Franco, 2006). 
Women with just one lifetime sexual partner still have an 84% risk of acquiring an HPV 
infection, and so monogamy, which is usually equated with safe sex, cannot be considered a 
protective factor in this case (Chesson, Dunne, Hariri, & Markowitz, 2014). Previous research 
that has examined this concept has been qualitative in nature, therefore this study developed a 
measure to quantitatively examine the association between these relationship status and HPV 
vaccination behavior. 
The purpose of this study was to develop and pilot test a quantitative measure based on 
previous qualitative research done by Dr. Thompson on relationship status as a risk factor for 
non-vaccination in women 18-26 years old. Her research used in-depth interviews conducted 
among college-aged women to collect data and requires further quantitative research to validate 
the findings (Thompson et al., 2017). Women in long-term relationships or who have had few 
sexual partners have a lower perceived risk and perceived severity of contracting HPV and are 
therefore less likely to participate in the catch-up phase of HPV vaccination (Thompson et al., 






2017). Women who are dating or have multiple sexual partners have a higher perceived risk and 
perceived severity of contracting HPV and are therefore more likely to participate in the catch-up 
phase of the HPV vaccine (Thompson et al., 2017). This trend exists even though relationship 
status has little effect on whether or not a sexually active female will develop an HPV infection 
at some point in her life. 
The quantitative nature of this present study acted as a supplement to the qualitative 
research done by Dr. Thompson. This study may provide a framework for further quantitative 
studies on this subject by providing a structure for future studies and by determining the 
feasibility, reliability, and validity of the survey instrument that was developed. Two similar 
studies have been conducted at a New York university and a southern Californian university, 
which were used to study the factors that influence a collegiate woman’s decision to engage in 
HPV vaccination. In 2010, undergraduate females at a large public university in New York State 
participated in a study that surveyed HPV vaccination beliefs among this age group, and how 
they impact a young woman’s decision to participate in the catch-up phase of the vaccine 
(Bednarczyk, Birkhead, Morse, Doleyres, & McNutt, 2011). At a large public university in 
southern California, a similar study was conducted among female undergraduates. That study 
used an electronic survey to examine the factors that influenced individuals in this target 
population’s decision to receive the HPV vaccine (Ratanasiripong, Cheng, & Enriquez, 2013). 
Whereas both of these previous studies found that relationship status was among the 
myriad of contributing influences over women receiving the HPV vaccination in the catch-up 
period, neither focused on this factor in particular. Therefore, this study provides an important 
addition to the literature, because it not only contributes to this growing wealth of information 
surrounding HPV vaccination behaviors in young adult females, but it is also unique in that it 






was conducted in the mid-Atlantic region and focused on relationship status as an influencing 
factor over a college woman’s decision to receive the HPV vaccine. This survey also served an 
important purpose as it is the first measure that collects data on HPV beliefs among female JMU 
students. Currently, there are no available data on the beliefs that JMU students harbor about 
HPV or the vaccine, much less how relationship status may affect the vaccination behaviors of 
James Madison University’s female students. The research questions that were examined in this 
study were: 
1. Does relationship status affect likelihood of being vaccinated during the catch-
period of vaccination among JMU females? 
2. Does relationship status predict intention to vaccinate among JMU females who 
are not previously vaccinated? 
Methodology 
Procedures 
The method of this study was the development of a quantitative survey instrument 
distributed among females 18-26 years old who attend a large public university in the mid-
Atlantic region. Before beginning the study, IRB approval was obtained and the cover letter can 
be found in Appendix A. This study occurred in two parts, survey development and cognitive 
interviewing. Cognitive interviewing involved eight participants. In order to recruit participants 
for cognitive interviews, cash incentives ($5) were offered to eligible participants. Eligible 
participants were full-time, female JMU students betweent the ages of 18-26 who knew their 
vacination status. Recruitment was done by emails sent to students enrolled in a class with the 
researcher after obtaining professor permission. Potential participants were then directed to a 
Qualtrics survey to determine their eligibility for participation in cognitive interviews. 






Participants were eligible for cognitive interviewing if they were full-time female students at 
JMU between the ages of 18-26 and fit into a stratification group. Stratification groups are 
subsets of the population based on factors of interest, which in this case were vaccination status 
and relationship status. Participants who met these criteria were contacted and an in-person 
interview was scheduled to occur on JMU’s campus. During the interview, the participant 
completed the initial survey via Qualtrics on either a laptop or smartphone, and was asked to 
think out loud as they answered each item. In particular, the researcher asked the participant to 
identify any areas of confusion they have regarding question wording and format. Based on the 
findings of cognitive interviews, modifications were then made to the survey. 
Once the cognitive interviews were completed, the final version of the survey was 
distributed to 13,000 female JMU students via a bulk email with a link to an electronic Qualtrics 
survey. In order to recruit participants for completion of the finalized online survey, entry into a 
lottery for a cash incentive ($10) was offered. After completion of the survey, participants 
followed a separate link to another Qualtrics survey to input their name and email address for the 
incentive lottery so that names and email addresses were not connected to survey data. A random 
number generator was used to select five participants to receive the incentive. Once the survey 
was closed, the researcher in association with her project advisors completed data cleaning, 
descriptive statistics, and chi-square analyses on the data. 
Measures 
 Independent variables measured in this study included relationship status, HPV 
knowledge, attitude toward relationships, HPV risk perception, and attitude toward the HPV 
vaccine. To understand the relationship status of individuals, they were asked to select their 
current relationship status as: Married or living with a partner, Not married, but in a long-term, 






monogamous relationship (You are committed to one person), Single and dating (You are seeing 
people but not committed to one person), or Single and not dating (You are not seeing anyone). 
These relationship statuses were adapted from Dr. Thompson’s work and then modified after 
cognitive interviewing. This was a necessary step because participants in cognitive interview 
generally did not understand what category they belonged in, and felt that they needed further 
clarification on the specifications of each status. The HPV Knowledge Scale used in this study 
was in true/false/unsure format and was adopted from a scale previously used in HPV research 
(Thompson, Vamos, Griner, & Daley, 2016). Three different five-point Likert Scales were 
developed and used to examine attitudes toward relationship, risk perception, and attitude toward 
HPV vaccination. The answer choices ranged from “Strongly Disagree” to “Strongly Agree.” 
The scale on attitudes toward relationship helped the researcher further determine what each 
status meant to an individual, and the level of commitment they have to a partner. This was 
necessary because it further clarifies whether or not relationship status affects participation in 
catch-up vaccination. The scale on risk perception was necessary because it helped determine the 
HPV risk perception each relationship status held. The scale on attitudes toward vaccination 
helped the researcher determine if the different relationship statuses affected attitude toward 
vaccination.  
The dependent variables measured in this study were HPV vaccination status and 
intention to vaccinate among previously unvaccinated individuals. In order to understand the 
vaccination status of participants, the researcher asked whether the participants had received the 
vaccine, at what age they received their first dose, and how many doses they had received. For 
those participants who were unvaccinated, the researcher asked whether or not they intended to 
receive the vaccine, and if so when they anticipated receiving their first dose. The researcher also 






collected participant demographics including sex, age, year in college, race/ethnicity, sexuality, 
and health insurance status. The survey can be found in Appendix B.  
Participants 
 Participants in this study were full-time female students between the ages of 18-26 at 
JMU (enrolled in 12 credits or more if an undergraduate student or 9 credit hours or more if a 
graduate student in the Fall 2017 semester) who knew their HPV vaccination status. In order to 
conduct the preliminary cognitive interviews, participants were identified via class lists in the 
researcher’s classes with professor permission. There were a total of eight cognitive interview 
participants, with four of the eight proposed stratification groups represented. A breakdown of 
the represented stratification groups in the cognitive interviews is shown in Table 1. Participants 
in the final survey were identified through a bulk email request, which was delivered to 13,000 
female JMU students. Before participation in the survey, participants had to read the cover letter 
that can be found in Appendix A and provide consent. After consenting, 736 were eligible to 
participate based on their gender, age, full-time student status, and knowledge of their HPV 
vaccination status. Six hundred and twenty nine of these participants completed the final survey, 
creating a completion rate of 85.46%. 
Analysis  
The survey was sent to 13,000 female JMU students, of whom 822 began the survey, and 
629 eligible participants completed it. Only the responses from participants who were eligible 
and who fully completed the survey were used for analysis (N=629). Bivariate and descriptive 
statistics were completed using SPSS 24 to explore differences in likelihood of vaccination 
during the catch-up age-range and intention to vaccinate by relationship status. This included 
chi-square tests and odds ratios with 95% confidence intervals to estimate associations for each 






category of relationship (Single and not Dating, Single and Dating, Long-Term, Monogamous 
Relationship, or Married or Living with a Partner) to 1 - Participation in HPV Catch-Up 
Vaccination and 2 - Intention to Participate in HPV Catch-Up Vaccination. In order to complete 
the chi-squares, the researcher recoded HPV vaccination status and age of first dose into a new 
variable, participation in HPV catch-up vaccination. This variable separated participants into two 
distinct groups: individuals who were vaccinated and who had received their first dose after age 
18, and other participants. The second variable that the researcher recoded for use in the chi-
squares was intention to participate in HPV catch-up vaccination. This variable was created 
using HPV vaccination status and intention to vaccinate, and again separated participants into 
two distinct groups: unvaccinated individuals who intended to receive the HPV vaccine, and 
unvaccinated individuals who either did not intend or were unsure of their intent to receive the 
vaccine. Relationship statuses were also recoded in order to conduct chi-squares. Four new 
variables were created that distinguished one relationship group from all of the others: “Married 
or living with a Partner v. Others”, “Long-Term, Monogamous relationship v. Others”, “Single 
and Dating v. Others”, and “Single and not Dating v. Others.” Due to the shortage of participants 
who were married or living with a partner, a new variable was created that merged this status 
with long-term, monogamous relationship status in order to observe if any new effect was found. 
Again, this variable was recoded to distinguish it from other statuses as “Married or 
Monogamous v. Others.” 
Results 
Demographics 
Of the 13,000 female students who received the survey, 822 began it generating a 
response rate of 6%. There were 629 eligible and complete responses that were used for analysis. 






All were female full-time students at JMU who were between the ages of 18-26 and knew their 
HPV vaccination status. Most participants were Caucasian (82.5%) and non-Hispanic/Latino 
(94.4%), with a minority (6.7%) of participants who reported being more than one race. Most 
were undergraduate students (92.8%), with 28.3% freshman, 16.5% sophomores, 25.3% juniors, 
and 22.7% seniors. Heterosexuality was the most common reported sexuality (88.4%) and 
bisexuality was the second most reported (7.5%). Most participants were privately insured 
(94.0%) and had had sexual intercourse (75.2%). A breakdown of participant demographics can 
be found in Table 2. 
The most common relationship status recorded in this study was Long-Term, 
Monogamous Relationship (n = 264) and the least common was Married or Living with a Partner 
(n = 14). A breakdown of the relationship groups can be seen in Table 3. Of currently sexually 
active participants, the largest single group reported that they always used a condom or 
protective barrier method with their current partner(s) (24.8%) and occasionally engaged in 
sexual activity under the influence of alcohol or drugs (44.2%). A small percentage (5.9%) of 
participants had been diagnosed with an STD/STI at some point, and a majority of those with a 
history of STI/STD had informed their partner(s) of this condition (75.6%).  
Most participants had received the HPV vaccine (79.0%), of which 7.9% received the 
vaccine during the catch-up period from ages 18-26. Of those who had not yet received the 
vaccine, 15.2% intended to receive it. The most commonly cited influencing factor for 
receiving/not receiving the vaccine was parents/guardians (82.2%). A majority of participants 
were aware of the recommended ages for HPV vaccination (77.9%) and were aware of the 
availability of a catch-up period of vaccination (79.3%). A majority of participants had never 
received a Pap-smear before (64.1%) and of the ones who had, most had never received an 






abnormal Pap-smear (81.9%). Only two participants had ever been diagnosed with genital warts 
(0.3%). Most participants indicated that they had no family history of HPV-associated cancers 
(71.2%), but of those participants with a history, the most commonly cited was cervical cancer 
(22.7%). 
Knowledge Scale 
HPV-related knowledge of participants was low. Significant findings included that most 
participants were unsure about or incorrectly reported that HPV can caused HIV/AIDS (n = 387, 
61.5%). Most participants were also unsure about or reported that HPV can cause herpes (n = 
409, 65%). A majority of participants did not know that HPV can cause anal (n = 466, 74.1%), 
oral (n = 464, 73.8%), and penile cancer (n = 432, 68.7%). There was also a lack of knowledge 
that there is no routine screening for oral cancer (n = 504, 80.1%) or routine HPV screening for 
men (n = 487, 77.4%). Most did not realize the HPV cannot be cured (n = 348, 55.3%), and 
lastly, a majority of participants either were unsure or answered that “Most sexually active 
people will get HPV” was false (n = 522, 83.0%). A full breakdown of the knowledge scale 
results can be found in Table 4.  
Research Question 1 - Does relationship status affect likelihood of being vaccinated during the 
catch-period of vaccination among JMU females? 
Single and Dating women were more likely to be vaccinated during the catch-up period 
compared to all other relationship statuses (X2 (1) = 4.87, p < 0.05; OR = 0.49, 95% CI 0.25 – 
0.93). Single and not Dating status was not significantly associated with vaccination during the 
catch-up period compared to all other relationship statuses (X2 (1) = 0.71, p < 0.05; OR = 1.12, 
95% CI 0.61 - 2.06). Long-Term, Monogamous Relationship status was not significantly 
associated with vaccination during the catch-up period compared to all other relationship statuses 






(X2 (1) = 0.27, p < 0.05; OR = 1.41, 95% CI 0.76 - 2.61). Married or Living with a Partner status 
was not significantly associated with vaccination during the catch-up  period compared to all 
other relationship statuses (X2 (1) = 0.31, p < 0.05; OR = 1.11 , 95% CI 1.08 - 1.15). Married or 
Living with a Partner status combined with Long-Term, Monogamous Relationship status was 
not significantly associated with vaccination during the catch-up period compared to all other 
relationship statuses (X2 (1) = 0.17, p < 0.05; OR = 1.53 , 95% CI 0.83 - 2.83). 
Research Question 2 - Does relationship status predict intention to vaccinate among JMU 
females who are not previously vaccinated? 
Single and Dating women were more likely to intend to vaccinate if previously 
unvaccinated compared to all other relationship statuses (X2 (1) = 4.87, p < 0.05; OR = 0.49, 
95% CI 0.25 – 0.93). Single and not Dating status was not significantly associated with intention 
to vaccinate among unvaccinated individuals compared to all other relationship statuses (X2 (1) = 
0.77, p < 0.05; OR = 0.87, 95% CI 0.33 - 2.29). Long-Term, Monogamous Relationship status 
was not significantly associated with intention to vaccinate among unvaccinated individuals 
compared to all other relationship statuses (X2 (1) = 0.98, p < 0.05; OR = 0.99, 95% CI 0.38 - 
2.57). Married or Living with a Partner status was not significantly associated with intention to 
vaccinate among unvaccinated individuals compared to all other relationship statuses (X2 (1) = 
0.34, p < 0.05; OR = 1.19, 95% CI 1.10 - 1.28). Married or Living with a Partner status 
combined with Long-Term, Monogamous Relationship status was not significantly associated 
with intention to vaccinate among unvaccinated individuals compared to all other relationship 
statuses (X2 (1) = 0.74, p < 0.05; OR = 1.18 , 95% CI 0.45 - 3.07).  
A cross tabulation showed that women who were “Single and Dating” had a higher risk 
perception of contracting HPV. When asked to respond to “I am at risk for contracting HPV”, 






27.93% of Single and Dating women somewhat agreed or strongly agreed. This is compared to 
the proportion of Single and not Dating women (12.92%), Long-term, Monogamous women 
(9.09%), and Married women (7.14%) who somewhat or strongly agreed with this statement.  
Discussion  
 This study found that Single and Dating status was the only relationship status that was 
significantly associated with participation in HPV catch-up vaccination and intention to 
vaccinate among those who had not yet received the HPV vaccine. This may be because those 
who are in this group have an increased risk perception of contracting HPV. This finding is 
important because no previous literature indicates that such a relationship status could be 
perceived as a protective factor for vaccination. This association may indicate that women in this 
group have a more accurate risk perception of their risk for HPV infection and therefore may be 
likely to participate in catch-up vaccination. This could be because women in this group may 
understand more about sexual behaviors and the associated risks than women who are not dating 
or are monogamous. HPV risk perception is counterintuitive to other STIs/STDs as being in a 
monogamous relationship is not a protective factor against infection. The counterintutive risk 
perception of HPV is due to its nature of transmission, as penetrative sex is not the only means of 
transmission; HPV can be spread through mucuosal transmission. The implication of this finding 
is that raising the risk perception across the other relationship groups may serve as an effective 
means of increasing catch-up participation. The cross-tabulation that was conducted indicates 
that this finding (Single and Dating status was a protective factor for HPV vaccination) may be 
based on their risk perception for HPV infection. 
 This study also found that monogamy was not a risk factor for non-participation in HPV 
catch-up vaccination. This finding was surprising as previous qualitative literature has found this 






relationship status to be an important barrier to receiving the HPV vaccine for young adult 
females (Thompson et al., 2017). One reason for this discrepancy could be that JMU does not 
have a large enough population of women who are married or living with a partner, so any 
association between this group and non-participation in HPV catch-up vaccination may have 
been hidden. Further, many of the women who were in a monogamous relationship or married in 
this study were vaccinated at a young age, and so did not have the opportunity to participate in 
catch-up vaccination. Of the nine married women who were vaccinated, six were vaccinated 
before age 17 (66.67%). Annecdottaly, JMU is a traditional campus and the students are young, 
which means they are more likley to live in single-gender housing. The high proportion of 
females at JMU also indicates that there may be less of an opportunity for heterosexual 
relationships. Of the 205 monogamous women who were vaccinated, 159 were vaccinated before 
age 17 (77.56%). This means that there was a smaller proportion of women who were married or 
monogamous and still unvaccinated, affecting the association between this relationship status 
and intention to vaccinate as well.  
The recorded vaccination rate was higher than anticipated. This may be because the JMU 
student body tends to be of higher socioeconomic background and therefore may have less of a 
stigma against the vaccine and better access to vaccination. The median family income of JMU 
students is about $147,000 and nearly 70% of the student body comes from the top 20% (Chetty, 
Friedman, Saez, Turner, & Yagan, 2017). These numbers are both considered high among 
Virginian schools and selective public schools within the United States (Chetty et al., 2017). 
Previous studies have found that family income level and having health insurance, especially 
private health insurance, is associated HPV vaccination state-by-state (Pruitt & Schootman, 
2010). Females from families in states with higher levels of poverty within the United States 






were less likely to receive the vaccine (Pruitt & Schootman, 2010). There is also a small number 
of students at JMU who are first-generation college students, which may have contributed to the 
high vaccination rate. JMU began collecting information on its first-generation college students 
in 2016, and it was reported in 2018 that 540 sophomores and 632 freshmen enrolled at JMU 
who were classified as such (Lewis, 2018). A previously conducted study found that females 
whose parents had completed college/some college were more likely to have received the HPV 
vaccine compared to those females whose parents obtained a high school education or less 
(Brewer et al., 2011). 
 In addition, JMU female students’ knowledge about HPV was varied. There was a 
significant deficit concerning knowledge of what constituted an HPV-related condition, who is at 
risk for infection, and measures of screening. Most participants correctly identified that HPV 
infection is associated with cervical cancer, but failed to realize that it is also associated with 
anal, penile, and oral cancers. This indicates that there is a need for increased knowledge across 
JMU’s campus about HPV and its implications. There were, however, some areas that the 
majority of participants were knowledgeable about, including the fact that both men and women 
can be infected with HPV and it can be spread without a person’s knowledge. 
Strengths and Limitations  
 The strengths of this survey include its sample size, the use of cognitive interviews, the 
use of previously validated instruments where possible, and the study design based on formative 
research. This survey was distributed to 13,000 individuals of which 629 completed it, leaving a 
large sample size used for analysis. The use of cognitive interviews while developing this survey 
created a finalized instrument that was less prone to wording and formatting errors, and therefore 
more accurate in its collection of data. Previously validated instruments were adapted for use in 






this survey where possible, including the HPV knowledge scale that was developed by Dr. Daley 
and adapted by Dr. Thompson (Thompson et al., 2016). The study design grew from this 
previous qualitative research, which increased its strength. With a basis in this formative 
research, the developed survey instrument was more directed in the data collected and justified in 
the survey items. 
The limitations of this study included the unique characteristics of the student population 
which limited variability in married/monogamous relationship status. Because JMU is a 
traditional university with mainly undergraduate students, very few are married or living with a 
partner. As of Fall 2017, 20,779 students were undergraduates and 1,888 were graduate students 
(James Madison University, 2018). This limited number may have led to an inaccurate 
representation of the association between this relationship status and participation in the catch-up 
period of vaccination. Further, JMU is geographically isolated in the Shenandoah Valley region 
which also contributes to a limited number of older/non-traditional students within the 
population.  
JMU demographics vary significantly from other universities in the nation and therefore 
may not be generalizable. Most of the students are white, female, and come from high-income 
families. About 74% of all JMU students were white in 2017, compared to the national average 
in 2015 of 57.6% of white students at all universities (James Madison University, 2017; National 
Center for Education Statistics [NCES], 2015). The student body at JMU is composed of 40% 
males and 60% females as of Fall 2017, which is similar to the national average of 56.37% 
female students and 43.62% male students (James Madison University, 2018; NCES, 2015). As 
previously mentioned, the median household income of JMU students’ family’s is $147,000 






(Chetty et al., 2017). This is higher than the national average household income of university 
students, which is $72,710 (The College Board, 2016).  
Another limitation of this study was that not all stratification groups were represented in 
the original cognitive interviews. No participants were “Married or Living with a Partner”, which 
shows a critical underrepresentation of this group throughout the entire study. No unvaccinated 
individuals from the “Single, Not Dating” and “Single and Dating” statuses were represented 
during cognitive interviews, either. The final survey, therefore, may have included potential 
wording and formatting issues that disproportionately affected unvaccinated individuals.  
A final limitation of this study was the response rate of 6%. The survey was 
electronically distributed to 13,000 participants, 822 of whom began the survey. Of these 822, 
736 were eligible for participation. In total, 629 eligible participants fully completed the survey. 
A low response rate can be expected due to the nature of this study, as response rates of online 
surveys tend to be reduced compared to paper-based surveys (Nulty, 2008). The completion rate 
of this survey was 85.46%. Participants were most likely to drop out after selecting which 
cancers family members had had and before completing the relationship and/or risk scales. The 
group who did not complete the survey was not significantly different from the group who did, 
except for comparison on two factors. The incomplete group was less likely to have received the 
HPV vaccine (46.3%) and more likely to have been diagnosed with an STD/STI (41.5%). 
Reasons for non-completion may include the length of the survey, lack of interest in the topic, 
and the personal nature of the questions.  
Suggestions for Future Research 
Future research should continue to examine relationship status as a barrier to participation 
in catch-up vaccination. Researchers should focus on verifying that Single and Dating 






relationship status is a potential protective factor for receiving HPV vaccine. They should 
continue to examine whether or not monogamous relationships and being married are a risk 
factor for non-participation in this catch-up period. To do so, studies should be conducted at non-
traditional universities where married women are more represented within the student body. 
Additionally, future studies should be conducted at universities with more socioeconomic and 
racial diversity. As future research continues to examine the association between these factors, 
the growing wealth of knowledge should be used to create programs designed to decrease 
barriers for participation in HPV catch-up vaccination and increase risk perception across all 
relationship statuses.  
 Conclusion 
This study examined the association between relationship status and HPV vaccination 
among JMU female students. The collection of these data may be useful to the university in 
future health campaigns surrounding HPV and vaccination on campus. Such efforts should work 
to promote HPV awareness, including awareness of how the infection is contracted, who is at 
risk, and what the consequences may be. JMU could also use these data to promote the 
opportunity for its students to participate in catch-up vaccination and why it is important that 
they do so. This study was unique in its region and specificity, and could help the JMU 
community by providing foundational information concerning the need for HPV educational 
campaigns and increasing the participation in the HPV vaccination catch-up schedule. Future 
research should continue to build on this topic by verifying the association found here and 
further examining the role of monogamous relationships as a barrier to participation in the HPV 
catch-up period of vaccination. More studies need to be done at non-traditional universities 
where the population of married women and those living with a partner is greater. As the wealth 






of knowledge around HPV vaccination behavior continues to grow, health professionals at 
various universities will gain a new set of data that will help them determine how to effectively 
promote participation in HPV catch-up vaccination. This has the potential to prevent HPV-
associated cancers and improve the health of college women across the United States.   







Bednarczyk, R. A., Birkhead, G. S., Morse, D. L., Doleyres, H., & McNutt, L. A. (2011). Human 
papillomavirus vaccine uptake and barriers: Association with perceived risk, actual risk 
and race/ethnicity among female students at a New York state university. Vaccine, 
29(17), 3138-3143. http://dx.doi.org/10.1016/j.vaccine.2011.02.045 
Brewer, N. T., Gottlieb, S. L., Reiter, P. L., McRee, A. L., Liddon, N., Markowitz, L., et al. 
(2011). Longitudinal predictors of human papillomavirus vaccine initiation among 
adolescent girls in a high-risk geographic area. Sexually Transmitted Diseases, 38(3), 
197-204. http://dx.doi.org/10.1097/OLQ.0b013e3181f12dbf 
Burchell, A. N., Winer, R. L., de Sanjose, S., & Franco, E. L. (2006). Epidemiology and 
transmission dynamics of genital HPV infection. Vaccine, 24(3), 52-61. 
http://dx.doi.org/10.1016/j.vaccine.2006.05.031 
Centers for Disease Control and Prevention. (2017). Genital HPV infection – Fact sheet. 
Updated January 3, 2017. Retrieved from https://www.cdc.gov/std/hpv/stdfact-hpv.htm 
Chesson, H., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014). The estimated lifetime 
probability of acquiring human papillomavirus in the United States. Sexually Transmitted 
Diseases, 41(11), 660-664. http://dx.doi.org/10.1097/OLQ.0000000000000193 
Chetty, R., Friedman, J. N., Saez, E., Turner, N., & Yagan, D. (2017). Mobility report cards: The 
role of colleges in intergenerational mobility. Retrieved from http://www.equality-of-
opportunity.org/data 
The College Board. (2016). Family income by selected characteristics, 2016 - Trends in higher 
education. Retrieved from https://trends.collegeboard.org/college-pricing/figures-tables 
/family-income-selected-characteristics-2016 






James Madison University. (2017). James madison university - Statistical summary 2017. 
Retrieved from https://www.jmu.edu/oir/oir-research/statsum/2017-18/T2-7_2017.pdf 
James Madison University. (2018). James madison university - Facts and figures. Retrieved from 
http://www.jmu.edu/about/fact-and-figures.shtml 
Lewis, K. (2018). Helping first-generation college students succeed. Retrieved from 
https://www.jmu.edu/cfi/_files/teaching-toolbox-03.15.18.pdf 
Markowitz, L. E., Dunne, E. F., Saraiya, M., Chesson, C. R., Gee, J., Bocchini, J. A., & Unger, 
E. R. (2014). Human papillomavirus vaccination: Recommendations from the advisory 
committee on immunization practices (ACIP). Morbidity and Mortality Weekly Report, 
63, 1-30. Retrieved from https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6305a1.htm 
National Center for Education Statistics. (2015). Fast facts: Back to school statistics. Retrieved 
from https://nces.ed.gov/fastfacts/display.asp?id=372 
Nulty, D. D. (2008). The adequacy of response rates to online and paper surveys: What can be 
done? Assessment and Evaluation in Higher Education, 33(3), 301-314. 
https://doi.org/10.1080/02602930701293231  
Pruitt, S. L. & Schootman, M. (2010). Geographic disparity, area poverty, and human 
papillomavirus vaccination. American Journal of Preventative Medicine, 38(5), 525-533. 
https://doi.org/10.1016/j.amepre.2010.01.018 
Rambout, L., Tashkandi, M., Hopkins, L., & Tricco, A. C. (2014). Self-reported barriers and 
facilitators to preventive human papillomavirus vaccination among adolescent girls and 
young women: A systematic review. Preventive Medicine, 58, 22–32. 
http://dx.doi.org/10.1016/j.ypmed.2013.10.009 
Ratanasiripong, N. T., Cheng, A. L., & Enriquez, M. (2013). What college women know, think, 






and do about human papillomavirus (HPV) and HPV vaccine. Vaccine, 31(10), 1370-
1376. http://dx.doi.org/10.1016/j.vaccine.2013.01.001 
Saslow, D., Castle, P. E., Cox, J. T., Davey, D. D., Einstein, M. H., Ferris, D. G., Goldie, S. J., 
Harper, D. M., Kinney, W., Moscicki, A. B., Noller, K. L., Wheeler, C. M., Ades, T., 
Andrews, K. S., Doroshenk, M. K., Kahn, K. G., Schmidt, C., Shafey, O., Smith, R. A., 
Partridge, E. E., & Garcia, F. (2007). American cancer society guideline for human 
papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. C.A.: A 
Cancer Journal for Clinicians, 57(1), 7-28. http://dx.doi.org/10.3322/canjclin.57.1.7 
Schmidt, S. & Parsons, H. M. (2014). Vaccination interests and trends in human papillomavirus 
vaccine uptake in young adult women aged 18 to 26 years in the United States: An 
analysis using the 2008-2012 national health interview survey. American Journal of 
Public Health, 104(5), 946-953. http://dx.doi.org/10.2105/AJPH.2013.301828 
Thompson, E. L., Vamos, C. A., Griner, S. B., & Daley, E. M. (2016). Changes in HPV 
knowledge among college women from 2008 to 2015. Journal of Cancer Education, 1-6. 
http://dx.doi.org/10.1007/s13187-016-1068-4 
Thompson, E. L., Vamos, C. A., Straub, D. M., Sappenfield, W. M., & Daley, E. M. (2017). 
“We’ve been together. We don’t have it. We’re fine.” How relationship status impacts 
human papillomavirus vaccination behavior among young adult women. Women’s Health 
Issues, 27(2), 228-236. http://dx.doi.org/10.1016/j.whi.2016.09.011 
Walker, T. Y., Elam-Evans, L. D., Singleton, J. A., Yankey, D., Markowitx, L. E., Fredua, B., 
Williams, C. L., Meyer, S. A., & Stokley, S. (2017). National, regional, state, and 
selected local area vaccination coverage among adolescents aged 13–17 years — United 

















Table 1. Cognitive Interview Stratification Groups (n = 8) 
  Vaccinated Unvaccinated 
Single, not dating 2 0 
Dating, but not monogamous 2 0 
Monogamous relationship 2 2 
Married or living with partner 0 0 
 
Table 2. Demographics of Analytic Sample (n = 629) 
Variable Responses Frequency Percentage 

























Prefer not to answer 
  
Other 








 n  % 
519 82.5 



































Table 3. Relationship Status (n = 629) 
Relationship Status Frequency Percent 
Not married, but in a long-
term, monogamous 
relationship (You are 
committed to one person) 
264 42.0 
Single and not dating (You 
are not seeing anyone) 
240 38.2 
Single and dating (You are 
seeing people but not 
committed to one person) 
111 17.6 












Table 4. HPV Knowledge Scale Results (n = 629) 
HPV Knowledge Scale Item CORRECT INCORRE
CT* 
HPV can cause HIV/AIDS 242 (38.5%) 387 (61.5%) 
HPV can cause abnormal Pap smears in women 390 (62%) 239 (38%) 
HPV can cause herpes 220 (35%) 409 (65%) 
HPV can affect a woman’s ability to get pregnant 571 (90.8%) 58 (9.2%) 
HPV can cause genital warts 329 (52.3%) 300 (47.7%) 
HPV can be passed to a newborn at birth 567 (90.1%) 62 (9.9%) 
HPV can cause cervical cancer 458 (72.8%) 171 (27.2%) 
HPV can cause anal cancer 163 (25.9%) 466 (74.1%) 
HPV can cause oral cancer 165 (26.2%) 464 (73.8%) 
HPV can cause penile cancer 197 (31.3%) 432 (68.7%) 
There are many types of HPV 463 (73.6%) 166 (26.4%) 
Only men can get HPV 566 (90.0%) 63 (10.0%) 
You can have HPV without knowing it 548 (87.1%) 81 (12.9%) 
HPV is a virus 470 (74.7%) 159 (25.3%) 
Only women can get HPV 508 (80.8%) 121 (19.2%) 
HPV is a bacterial infection 335 (53.3%) 294 (46.7%) 
Some types of HPV cause cancer, and some do not 368 (58.5%) 261 (41.5%) 
HPV is a sexually transmitted infection 467 (74.2%) 162 (25.8%) 
Antibiotics can cure HPV 357 (56.8%) 272 (43.2%) 
Using a condom decreases the chance of HPV 
transmission 
517 (82.2%) 112 (17.8%) 
There is a vaccine for women that prevents certain 
types of HPV 
534 (84.9%) 95 (15.1%) 
You can always tell when someone else has HPV 550 (87.4%) 79 (12.6%) 






HPV is spread on toilet seats 391 (62.2%) 238 (37.8%) 
Even if you do not see a wart, you can transmit 
HPV 
467 (74.2%) 162 (25.8%) 
There is routine screening for oral cancer 125 (19.9%) 504 (80.1%) 
There is a vaccine for men that prevents certain 
types of HPV 
293 (46.6%) 336 (53.4%) 
There is routine HPV screening for men 142 (22.6%) 487 (77.4%) 
Transmission of HPV can occur through sexual 
contact with another person 
526 (83.6%) 103 (16.4%) 
HPV can be cured 281 (44.7%) 348 (55.3%) 
Once you have HPV, you can never get rid of it 276 (43.9%) 353 (56.1%) 
Most sexually active people will get HPV 107 (17.0%) 522 (83.0%) 























Identification of Investigators & Purpose of Study  
You are being asked to participate in a research study conducted by Ansley Waters from James 
Madison University. The purpose of this study is to examine the association between HPV 
vaccination behavior and relationship status. This study will contribute to the researcher’s 
completion of her honors thesis.  
Research Procedures  
This study consists of an online survey that will be administered to individual participants 
through Qualtrics. You will be asked to provide answers to a series of questions related to HPV 
vaccination behavior and relationship status.  
Time Required  
Participation in this study will require 10 minutes of your time.  
Risks  
The investigator does not perceive more than minimal risks from your involvement in this study 
(that is, no risks beyond the risks associated with everyday life).  
Benefits  
Potential benefits from participation in this study include: contributing to the increasing wealth 
of information about HPV and HPV vaccination behavior, providing evidence for future health 
campaigns, and gaining awareness about HPV and the HPV vaccine.  
Confidentiality  
The results of this research will be presented at the JMU Honors Symposium. While individual 
responses are anonymously obtained and recorded online through the Qualtrics software, data is 
kept in the strictest confidence. No identifiable information will be collected from the participant 
and no identifiable responses will be presented in the final form of this study. All data will be 
stored in a secure location only accessible to the researcher. The researcher retains the right to 
use and publish non-identifiable data. At the end of the study, all records will be destroyed. Final 
aggregate results will be made available to participants upon request.  
Participation & Withdrawal  
Your participation is entirely voluntary. You are free to choose not to participate. Should you 
choose to participate, you can withdraw at any time without consequences of any kind. However, 
once your responses have been submitted and anonymously recorded you will not be able to 
withdraw from the study.  
Questions about the Study  
If you have questions or concerns during the time of your participation in this study, or after its 
completion or you would like to receive a copy of the final aggregate results of this study, please 
contact:  
 Ansley Waters                                                                 Laura Merrell  
 Health Sciences                                                               Health Sciences  
 James Madison University                                              James Madison University  
 Watersav@dukes.jmu.ed                                                 Telephone: (540) 568-4167  
                                                                                          Merrellk@jmu.edu 
 
 






Questions about Your Rights as a Research Subject  
Dr. David Cockley  
Chair, Institutional Review Board  
James Madison University  
(540) 568-2834 cocklede@jmu.edu  
Giving of Consent  
I have been given the opportunity to ask questions about this study. I have read this consent and I 
understand what is being requested of me as a participant in this study. I certify that I am at least 
18 years of age. By clicking on the link below, and completing and submitting this anonymous 
survey, I am consenting to participate in this research. 
  










(Cover letter & provide consent) 
 
Do you attend JMU full-time (Undergraduate student: registered for 12 credit hours or more this 
semester/Graduate student: registered for 9 credit hours or more this semester)?  
o Yes 
o No  
  
What is your age?  
________________________________________________________________ 
 
What is your sex? 
o Male   
o Female   
o Other  
o Prefer not to answer  
  
What is your year in school? 
o Freshman   
o Sophomore   
o Junior   
o Senior   
o Graduate student  
  
Are you Hispanic/Latino? 
o Yes   
o No   
  
What is your race? (Choose all that apply) 
▢         American Indian/Alaska Native  
▢         Asian   
▢         Black/African American   
▢         White   
▢         Other   
▢         Prefer not to answer   







Do you consider yourself to be: 
o Heterosexual or straight   
o Lesbian   
o Bisexual   
o Something else (please specify):  ________________________________________________ 
o Prefer not to answer   
  
Do you currently have health insurance? 
o I am covered under a private health insurance plan (on your parent's insurance, through your 
job, OR you pay for yourself).  
o I am covered under a public health insurance plan (Medicare or Medicaid).  
o I do not have health insurance   
o Unsure  
o Prefer not to answer  
  
Have you visited the JMU Health Center? 
o Never  
o Visited in the past month   
o Visited in the past 6 months   
o Visited in the past year  
o Visited over a year ago  
o Unsure  
  
When was the last time you visited a primary care physician? 
o Never   
o Visited in the past month   
o Visited in the past 6 months  
o Visited in the past year  
o Visited over a year ago  
o Unsure  
  
Did you receive the flu vaccine within the past calendar year? 
o Yes 
o No   






o Unsure  
 What is your current relationship status? 
o Married or living with a partner   
o Not married, but in a long-term, monogamous relationship (You are committed to one person)   
o Single and dating (You are seeing people but not committed to one person)   
o Single and not dating (You are not seeing anyone)   
 
When was the last time you started a new relationship? (Any relationship, casual or committed) 
o Not applicable  
o Within the last 3 months   
o Between 4-6 months ago   
o Between 7-12 months ago    
o Over a year ago    
o Unsure   
 
When was the last time you ended a relationship? (Any relationship, casual or committed)  
o Not applicable  
o Within the last 3 months   
o Between 4-6 months ago  
o Between 7-12 months ago    
o Over a year ago    
o Over five years ago  
o Unsure   
 
When do you anticipate starting a new relationship? (Any relationship, casual or committed)  
o Not anticipated in the foreseeable future   
o Anticipated within the next month   
o Anticipated within the next 6 months   
o Anticipated within the next year   













Display This Question: If What is your current relationship status? != Single and not dating 
(You are not seeing anyone) 
When do you anticipate ending a relationship? (Any relationship, casual or committed)  
o Not anticipated in the foreseeable future   
o Anticipated within the next month  
o Anticipated within the next 6 months   
o Anticipated within the next year   
o Unsure  
 
Have you ever had sexual intercourse?  
o Yes   
o No   
  
Have you ever had vaginal-penile intercourse? 
o Yes   
o No   
  
Have you ever had oral intercourse? 
o Yes  
o No   
  
Have you ever had anal intercourse? 
o Yes   
o No   
  
Display This Question: If Have you ever had sexual intercourse?  = Yes 
How many new sexual partners have you had within the past year?  
________________________________________________________________ 
  
Display This Question: If Have you ever had sexual intercourse?  = Yes 
Within the past year, how often did your current sexual partner(s) use a condom or protective 
barrier method? 
o No current partners within the past year   
o Never    
o Occasionally    
o Frequently    
o Always    







Within the past year, how often did you engage in sexual behavior while under the influence of 
alcohol or drugs?  
o No sexual behavior in the past year   
o Never   
o Occasionally   
o Frequently   
o Always   
  
Display This Question: If What is your current relationship status? != Single and not dating 
(You are not seeing anyone) 
Has your current partner(s) ever been diagnosed with an STI/STD? 
o Yes   
o No   
o Unsure   
 
Have you ever been diagnosed with an STI/STD?  
o Yes    
o No   
o Unsure  
  
Display This Question: If Have you ever been diagnosed with an STI/STD?  = Yes 
Did you inform your current partner(s) of your diagnosis? 
o Yes   
o No   
  
Have you received the HPV vaccine (also known as Gardasil or Cervarix)?  
o Yes  
o No   
o Unsure  
  
Display This Question: If Have you received the HPV vaccine (also known as Gardasil or 
Cervarix)?  = Yes 
Who decided that you would receive the HPV vaccine? 
o I did   
o A parent/guardian did    
o Joint decision    






o Unsure  
Display This Question: If Have you received the HPV vaccine (also known as Gardasil or 
Cervarix)?  = Yes 
How many doses of the HPV vaccine have you had? 
o One    
o Two    
o Three    
o Unsure 
 
Display This Question: If Have you received the HPV vaccine (also known as Gardasil or 
Cervarix)?  = Yes 
At what age did you receive your first dose of the HPV vaccine? 
o 11-12 years old   
o 13-17 years old   
o 18-26 years old    
o Unsure   
  
Display This Question: If Have you received the HPV vaccine (also known as Gardasil or 
Cervarix)?  = No 
Do you intend to receive the HPV vaccine? 
o Yes   
o No    
o Unsure   
  
Display This Question: If Do you intend to receive the HPV vaccine? = Yes 
When do you plan to receive your first dose of the HPV vaccine? 
o Within the next month   
o Within the next 6 months    
o Within the next year   
o More than a year from now   

















Who influenced your decision to receive (not receive) the HPV vaccine? (check all that apply) 
▢         Parents/Guardians   
▢         Other Family Member  
▢         Doctor   
▢         Nurse    
▢         Partner    
▢         Friend    
▢         School   
▢         Other (please specify): ________________________________________________ 
▢         None of these   
  
 Which of the following influenced your decision to receive (not receive) the HPV vaccine? 
(check all that apply)  
▢         Availability of vaccine  
▢         Cost of vaccine   
▢         Knowledge of vaccine   
▢         Relationship status   
▢         Safety of vaccine    
▢         Other (please specify):  ________________________________________________ 
▢         None of these   
  
To the best of your ability, please mark the following statements as true, false, or unsure. 
  True  False Unsure  
HPV can cause 
HIV/AIDS  
o   o   o   
HPV can cause 
abnormal Pap smears 
in women  
o   o   o   
HPV can cause 
herpes  
o   o   o   






HPV can affect a 
woman’s ability to 
get pregnant  
o   o   o   
HPV can cause 
genital warts 
o   o   o   
HPV can be passed 
to a newborn at birth  
o   o   o   
HPV can cause 
cervical cancer  
o   o   o   
HPV can cause anal 
cancer 
o   o   o   
HPV can cause oral 
cancer 
o   o   o   
HPV can cause 
penile cancer 
o   o   o   
There are many types 
of HPV 
o   o   o   
Only men can get 
HPV 
o   o   o   
You can have HPV 
without knowing it 
o   o   o   
HPV is a virus 
o   o   o   
Only women can get 
HPV 
o   o   o   






HPV is a bacterial 
infection 
o   o   o   
Some types of HPV 
cause cancer, and 
some do not 
o   o   o   
HPV is a sexually 
transmitted infection 
o   o   o   
Antibiotics can cure 
HPV 
o   o   o   
Using a condom 
decreases the chance 
of HPV transmission  
o   o   o   
There is a vaccine for 
women that prevents 
certain types of HPV  
o   o   o   
You can always tell 
when someone else 
has HPV 
o   o   o   
HPV is spread on 
toilet seats 
o   o   o   
Even if you do not 
see a wart, you can 
transmit HPV 
o   o   o   
There is routine 
screening for oral 
cancer 
o   o   o   






There is a vaccine for 
men that prevents 
certain types of HPV  
o   o   o   
There is routine HPV 
screening for men  
o   o   o   
Transmission of HPV 
can occur through 
sexual contact with 
another person 
o   o   o   
HPV can be cured  
o   o   o   
Once you have HPV, 
you can never get rid 
of it 
o   o   o   
Most sexually active 
people will get HPV  




Are you aware that the HPV vaccine is recommended for females ages 11-12? 
o Yes   
o No  
  
Are you aware that women who did not receive the HPV vaccine when they were younger could 
receive it when they are 13-26 years old? 
o Yes   
o No  
When was the last time you had a Pap Smear?  
o Never  
o Within the past year    
o 1-2 years ago  
o Over 2 years ago   












Display This Question: If When was the last time you had a Pap Smear?  != Never 
Have you ever had an abnormal Pap Smear? 
o Yes    
o No   
o Unsure  
  
Have you ever been diagnosed with genital warts?  
o Yes  
o No  
o Unsure   
 
Has an immediate family member ever been diagnosed with any of the following cancers (check 
all that apply): 
▢         Cervical   
▢         Vaginal   
▢         Uterine 
▢         Ovarian 
▢         Penile 
▢         Rectal  
▢         Oropharyngeal 
▢         None of these   
▢         Unsure   
  
Display This Question: If What is your current relationship status? != Single and not dating 
(You are not seeing anyone) 
Please indicate the extent to which you agree or disagree with the following statements. Answer 
with either your current partner or most recent partner in mind, or think of a hypothetical 
relationship.  
 

















I am invested 
in my current 
relationship(s)   
o   o   o   o   o   
My partner(s) 
and I have 
similar values  





to sexual and 
reproductive 
health with my 
partner(s) 
o   o   o   o   o   






o   o   o   o   o   










major decisions  
o   o   o   o   o   


















o   o   o   o   o   






with any new 
partner(s) 
o   o   o   o   o   
  
 Please indicate the extent to which you agree or disagree with the following statements. 
 











I am at risk 
for 
contracting 
an STD  
o   o   o   o   o   




o   o   o   o   o   




o   o   o   o   o   








with an STD 
is serious 






o   o   o   o   o   
Being 
diagnosed 
with HPV is 
serious  
o   o   o   o   o   
I am more 
likely than 
other women 
my age to be 
diagnosed 
with HPV 
o   o   o   o   o   
 
  
Please indicate the extent to which you agree or disagree with the following statements. The 
catch-up period of vaccination refers to how previously unvaccinated women can receive the 
HPV vaccine between the ages of 13-26.   
 

















o   o   o   o   o   




















up period of 
HPV 
vaccination 
o   o   o   o   o   















o   o   o   o   o   
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